Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on September 14, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on September 14, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 1,580 Common Stock at $502.15 ($793,399) on September 14, 2026; holds 332,363 after (Indirect).
- Open-market sale: disposed of 2,358 Common Stock at $503.44 ($1,187,113) on September 14, 2026; holds 330,005 after (Indirect).
- Open-market sale: disposed of 2,722 Common Stock at $504.47 ($1,373,180) on September 14, 2026; holds 327,283 after (Indirect).
- Open-market sale: disposed of 2,400 Common Stock at $505.25 ($1,212,609) on September 14, 2026; holds 324,883 after (Indirect).
- Open-market sale: disposed of 440 Common Stock at $506.48 ($222,851) on September 14, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on September 14, 2026; holds 442,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,789,152 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-09-14 | Open-market sale | Common Stock | 1,580 | $502 | $793.4K | 332,363 |
| 2026-09-14 | Open-market sale | Common Stock | 2,358 | $503 | $1.2M | 330,005 |
| 2026-09-14 | Open-market sale | Common Stock | 2,722 | $504 | $1.4M | 327,283 |
| 2026-09-14 | Open-market sale | Common Stock | 2,400 | $505 | $1.2M | 324,883 |
| 2026-09-14 | Open-market sale | Common Stock | 440 | $506 | $222.9K | 324,443 |
| 2026-09-14 | Option exercise/conversion | Stock Option | 9,500 | — | — | 442,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Option exercise/conversion (9,500 shares) |
| 2026-09-14 | Open-market sale (1,580 shares) |
| 2026-09-14 | Open-market sale (2,358 shares) |
| 2026-09-14 | Open-market sale (2,722 shares) |
| 2026-09-14 | Open-market sale (2,400 shares) |
| 2026-09-14 | Open-market sale (440 shares) |
| 2026-09-14 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.